These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4721223)

  • 1. Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.
    Cohen SM; Lower GM; Ertürk E; Bryan GT
    Cancer Res; 1973 Jul; 33(7):1593-7. PubMed ID: 4721223
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adult thymectomy and adult splenectomy on the production of leukemia and stomach neoplasms in mice by N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide.
    Cohen SM; Headley DB; Bryan GT
    Cancer Res; 1973 Apr; 33(4):637-40. PubMed ID: 4696463
    [No Abstract]   [Full Text] [Related]  

  • 3. Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Sep; 30(9):2320-5. PubMed ID: 5475478
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of p-hydroxyacetanilide, sodium sulfate, and L-methionine on the leukemogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Cohen SM; Bryan GT
    Cancer Res; 1978 May; 38(5):1398-405. PubMed ID: 639067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of antibody-mediated and cell-mediated murine immunity by the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Headley DB; Cohen SM; Bryan GT
    Cancer Res; 1977 Apr; 37(4):974-9. PubMed ID: 14783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of urinary bladder carcinomas in male hamsters by N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide, N-(4-(5-nitro-2-furyl)-2-thiazolyl)-acetamide, or formic acid 2-(4-(5-nitro-2-furyl)-2-thiazolyl)hydrazide.
    Croft WA; Bryan GT
    J Natl Cancer Inst; 1973 Sep; 51(3):941-9. PubMed ID: 4743562
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinogenicity of 5-nitrofurans and related compounds with amino-heterocyclic substituents.
    Cohen S; Ertürk E; Von Esch A; Corvetti A; Bryan G
    J Natl Cancer Inst; 1975 Apr; 54(4):841-50. PubMed ID: 165300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats.
    Ertürk E; Cohen SM; Bryan GT
    Cancer Res; 1970 Apr; 30(4):936-41. PubMed ID: 4323354
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
    Ertürk E; Cohen SM; Bryan GT
    Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
    [No Abstract]   [Full Text] [Related]  

  • 12. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
    Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinogenicity of potassium 1-methyl-7-(2-(5-nitro-2-furyl)-vinyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate in ICR mice.
    Kanisawa M; Kato H; Aiso K
    Gan; 1974 Feb; 65(1):1-11. PubMed ID: 4825387
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.
    Cohen SM; Ertürk E; Von Esch AM; Crovetti AJ; Bryan GT
    J Natl Cancer Inst; 1973 Aug; 51(2):403-17. PubMed ID: 4520099
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer.
    Tiltman AJ
    S Afr Med J; 1972 Mar; 46(11):293-4. PubMed ID: 5018148
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.
    Daly JJ; Prout GR; Ahl CA
    J Urol; 1973 Feb; 109(2):253-60. PubMed ID: 4631147
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice.
    Yoshida O; Ertürk E; Bryan GT; Lower GM
    Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
    Vlasov NN; Pliss GB; Balin VV
    Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic activity of 2-(2-furyl)-3-(5-nitro-2-furyl)-acrylamide, a food additive, in mice and rats.
    Takayama S; Kuwabara N
    Cancer Lett; 1977 Sep; 3(3-4):115-20. PubMed ID: 902249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.